Localization of Rheb to the endomembrane is critical for its signaling function

Biochemical and Biophysical Research Communications

Volumn 344, Issue 3, 2006, Pages 869-880

  Buerger, Claudia ^a   DeVries, Ben ^a   Stambolic, Vuk ^a  

^a PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

Farnesylation; mTOR; Protein translation signaling; Rheb; Subcellular localization

Indexed keywords

BREFELDIN A; ENHANCED GREEN FLUORESCENT PROTEIN; MAMMALIAN TARGET OF RAPAMYCIN; PROTEIN DERIVATIVE; RHEB PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL MEMBRANE; CELL STRUCTURE; CONTROLLED STUDY; CYTOPLASM; ENDOPLASMIC RETICULUM; GOLGI COMPLEX; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; RNA TRANSLATION; SIGNAL TRANSDUCTION;

CELL LINE; CELL MEMBRANE; GOLGI APPARATUS; HUMANS; KIDNEY; MONOMERIC GTP-BINDING PROTEINS; NEUROPEPTIDES; PROTEIN KINASES; SIGNAL TRANSDUCTION; SUBCELLULAR FRACTIONS;

ANIMALIA; MAMMALIA;

EID: 33646143793     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.03.220     Document Type: Article

References (42)

1. Li Y., Corradetti M.N., Inoki K., and Guan K.L. TSC2: filling the GAP in the mTOR signaling pathway. Trends Biochem. Sci. 29 (2004) 32-38
2. Manning B.D., and Cantley L.C. Rheb fills a GAP between TSC and TOR. Trends Biochem. Sci. 28 (2003) 573-576
3. Tee A.R., Manning B.D., Roux P.P., Cantley L.C., and Blenis J. Tuberous sclerosis complex gene products, Tuberin and Hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb. Curr. Biol. 13 (2003) 1259-1268
4. Zhang Y., Gao X., Saucedo L.J., Ru B., Edgar B.A., and Pan D. Rheb is a direct target of the tuberous sclerosis tumour suppressor proteins. Nat. Cell Biol. 5 (2003) 578-581
5. Stocker H., Radimerski T., Schindelholz B., Wittwer F., Belawat P., Daram P., Breuer S., Thomas G., and Hafen E. Rheb is an essential regulator of S6K in controlling cell growth in Drosophila. Nat. Cell Biol. 5 (2003) 559-565
6. Garami A., Zwartkruis F.J., Nobukuni T., Joaquin M., Roccio M., Stocker H., Kozma S.C., Hafen E., Bos J.L., and Thomas G. Insulin activation of Rheb, a mediator of mTOR/S6K/4E-BP signaling, is inhibited by TSC1 and 2. Mol. Cell 11 (2003) 1457-1466
7. Inoki K., Li Y., Xu T., and Guan K.L. Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling. Genes Dev. 17 (2003) 1829-1834
8. Saucedo L.J., Gao X., Chiarelli D.A., Li L., Pan D., and Edgar B.A. Rheb promotes cell growth as a component of the insulin/TOR signalling network. Nat. Cell Biol. 5 (2003) 566-571
9. Long X., Lin Y., Ortiz-Vega S., Yonezawa K., and Avruch J. Rheb binds and regulates the mTOR kinase. Curr. Biol. 15 (2005) 702-713
10. Jefferies H.B., Reinhard C., Kozma S.C., and Thomas G. Rapamycin selectively represses translation of the "polypyrimidine tract" mRNA family. Proc. Natl. Acad. Sci. USA 91 (1994) 4441-4445
11. Jefferies H.B., Fumagalli S., Dennis P.B., Reinhard C., Pearson R.B., and Thomas G. Rapamycin suppresses 5′TOP mRNA translation through inhibition of p70s6k. EMBO J. 16 (1997) 3693-3704
12. Beretta L., Gingras A.C., Svitkin Y.V., Hall M.N., and Sonenberg N. Rapamycin blocks the phosphorylation of 4E-BP1 and inhibits cap-dependent initiation of translation. EMBO J. 15 (1996) 658-664
13. Gingras A.C., Raught B., Gygi S.P., Niedzwiecka A., Miron M., Burley S.K., Polakiewicz R.D., Wyslouch-Cieszynska A., Aebersold R., and Sonenberg N. Hierarchical phosphorylation of the translation inhibitor 4E-BP1. Genes Dev. 15 (2001) 2852-2864
14. Gingras A.C., Raught B., and Sonenberg N. Regulation of translation initiation by FRAP/mTOR. Genes Dev. 15 (2001) 807-826
15. Boyartchuk V.L., Ashby M.N., and Rine J. Modulation of Ras and a-factor function by carboxyl-terminal proteolysis. Science 275 (1997) 1796-1800
16. Hancock J.F. Ras proteins: different signals from different locations. Nat. Rev. Mol. Cell Biol. 4 (2003) 373-384
17. Clark G.J., Kinch M.S., Rogers-Graham K., Sebti S.M., Hamilton A.D., and Der C.J. The Ras-related protein Rheb is farnesylated and antagonizes Ras signaling and transformation. J. Biol. Chem. 272 (1997) 10608-10615
18. Yang W., Tabancay Jr. A.P., Urano J., and Tamanoi F. Failure to farnesylate Rheb protein contributes to the enrichment of G0/G1 phase cells in the Schizosaccharomyces pombe farnesyltransferase mutant. Mol. Microbiol. 41 (2001) 1339-1347
19. Hancock J.F., Paterson H., and Marshall C.J. A polybasic domain or palmitoylation is required in addition to the CAAX motif to localize p21ras to the plasma membrane. Cell 63 (1990) 133-139
20. Michaelson D., Ali W., Chiu V.K., Bergo M., Silletti J., Wright L., Young S.G., and Philips M. Postprenylation CAAX processing is required for proper localization of Ras but not Rho GTPases. Mol. Biol. Cell 16 (2005) 1606-1616
21. Tee A.R., Blenis J., and Proud C.G. Analysis of mTOR signaling by the small G-proteins, Rheb and RhebL1. FEBS Lett. 579 (2005) 4763-4768
22. Saito K., Araki Y., Kontani K., Nishina H., and Katada T. Novel role of the small GTPase Rheb: its implication in endocytic pathway independent of the activation of mammalian target of rapamycin. J. Biochem. (Tokyo) 137 (2005) 423-430
23. Drenan R.M., Liu X., Bertram P.G., and Zheng X.F. FKBP12-rapamycin-associated protein or mammalian target of rapamycin (FRAP/mTOR) localization in the endoplasmic reticulum and the Golgi apparatus. J. Biol. Chem. 279 (2004) 772-778
24. Mitoma J., and Ito A. The carboxy-terminal 10 amino acid residues of cytochrome b5 are necessary for its targeting to the endoplasmic reticulum. EMBO J. 11 (1992) 4197-4203
25. Zhu W., Cowie A., Wasfy G.W., Penn L.Z., Leber B., and Andrews D.W. Bcl-2 mutants with restricted subcellular location reveal spatially distinct pathways for apoptosis in different cell types. EMBO J. 15 (1996) 4130-4141
26. Yamaguchi N., and Fukuda M.N. Golgi retention mechanism of beta-1,4-galactosyltransferase. Membrane-spanning domain-dependent homodimerization and association with alpha- and beta-tubulins. J. Biol. Chem. 270 (1995) 12170-12176
27. Chardin P., and McCormick F. Brefeldin A: the advantage of being uncompetitive. Cell 97 (1999) 153-155
28. Sebti S.M. Protein farnesylation: implications for normal physiology, malignant transformation, and cancer therapy. Cancer Cell 7 (2005) 297-300
29. Castro A.F., Rebhun J.F., Clark G.J., and Quilliam L.A. Rheb binds tuberous sclerosis complex 2 (TSC2) and promotes S6 kinase activation in a rapamycin- and farnesylation-dependent manner. J. Biol. Chem. 278 (2003) 32493-32496
30. Basso A.D., Mirza A., Liu G., Long B.J., Bishop W.R., and Kirschmeier P. The FTI SCH66336 (Lonafarnib) inhibits Rheb farnesylation and mTOR signaling: role in FTI enhancement of taxane and tamoxifen anti-tumor activity. J. Biol. Chem. (2005)
31. Gau C.L., Kato-Stankiewicz J., Jiang C., Miyamoto S., Guo L., and Tamanoi F. Farnesyltransferase inhibitors reverse altered growth and distribution of actin filaments in Tsc-deficient cells via inhibition of both rapamycin-sensitive and -insensitive pathways. Mol. Cancer Ther. 4 (2005) 918-926
32. Takahashi K., Nakagawa M., Young S.G., and Yamanaka S. Differential membrane localization of ERas and Rheb, two ras-related proteins involved in the PI3 kinase/mTOR pathway. J. Biol. Chem. (2005)
33. Yuan J., Shan Y., Chen X., Tang W., Luo K., Ni J., Wan B., and Yu L. Identification and characterization of RHEBL1, a novel member of Ras family, which activates transcriptional activities of NF-Kappa B. Mol. Biol. Rep. 32 (2005) 205-214
34. Jones K.A., Jiang X., Yamamoto Y., and Yeung R.S. Tuberin is a component of lipid rafts and mediates caveolin-1 localization: role of TSC2 in post-Golgi transport. Exp. Cell Res. 295 (2004) 512-524
35. Wienecke R., Maize Jr. J.C., Shoarinejad F., Vass W.C., Reed J., Bonifacino J.S., Resau J.H., de Gunzburg J., Yeung R.S., and DeClue J.E. Co-localization of the TSC2 product tuberin with its target Rap1 in the Golgi apparatus. Oncogene 13 (1996) 913-923
36. Nomura K., Kanemura H., Satoh T., and Kataoka T. Identification of a novel domain of Ras and Rap1 that directs their differential subcellular localizations. J. Biol. Chem. 279 (2004) 22664-22673
37. Chiu V.K., Bivona T., Hach A., Sajous J.B., Silletti J., Wiener H., Johnson II R.L., Cox A.D., and Philips M.R. Ras signalling on the endoplasmic reticulum and the Golgi. Nat. Cell Biol. 4 (2002) 343-350
38. Choy E., Chiu V.K., Silletti J., Feoktistov M., Morimoto T., Michaelson D., Ivanov I.E., and Philips M.R. Endomembrane trafficking of ras: the CAAX motif targets proteins to the ER and Golgi. Cell 98 (1999) 69-80
39. Bivona T.G., Perez De Castro I., Ahearn I.M., Grana T.M., Chiu V.K., Lockyer P.J., Cullen P.J., Pellicer A., Cox A.D., and Philips M.R. Phospholipase Cgamma activates Ras on the Golgi apparatus by means of RasGRP1. Nature 424 (2003) 694-698
40. Sarbassov D.D., Ali S.M., Kim D.H., Guertin D.A., Latek R.R., Erdjument-Bromage H., Tempst P., and Sabatini D.M. Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton. Curr. Biol. 14 (2004) 1296-1302
41. Sarbassov D.D., Guertin D.A., Ali S.M., and Sabatini D.M. Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307 (2005) 1098-1101
42. Matallanas D., Sanz-Moreno V., Arozarena I., Calvo F., Agudo-Ibanez L., Santos E., Berciano M.T., and Crespo P. Distinct utilization of effectors and biological outcomes resulting from site-specific Ras activation: Ras functions in lipid Rafts and Golgi complex are dispensable for proliferation and transformation. Mol. Cell Biol. 26 (2006) 100-116